Zacks Investment Research Analysis

Dollar Tree (DLTR) Q4 Earnings Beat Estimates, Sales Rise Y/Y By Zacks Investment Research - Mar 04, 2020

Dollar Tree, Inc. (NASDAQ:DLTR) reported fourth-quarter fiscal 2019 results, wherein earnings surpassed the Zacks Consensus Estimate but sales lagged the same. Although it witnessed drab holiday...

3 Cheap Stocks Under $10 To Buy After Market Correction As Coronavirus Fears Linger By Zacks Investment Research - Mar 04, 2020

The Dow, the S&P 500, and the Nasdaq all quickly plummeted into a correction last week as the coronavirus spreads outside of China. Apple (NASDAQ:AAPL) , Microsoft (NASDAQ:MSFT) , and others...

Ryanair's February Traffic Up, Coronavirus Spread Rampant By Zacks Investment Research - Mar 04, 2020

Ryanair Holdings (NASDAQ:RYAAY) posted impressive February traffic figures as air-travel demand was solid in the month. Traffic (including 0.5 million from its LaudaMotion unit in Austria) rose 9%...

How To Earn Solid Income With ETFs Amid Record-Low Yield? By Zacks Investment Research - Mar 04, 2020

The coronavirus scare has done what no global economic shock could do to the benchmark U.S. treasury yield. The 10-year Treasury bond yield dropped below 1% for the first time in history on Mar 3 and...

3 Cloud Stocks To Keep Your Portfolio Above The Coronavirus By Zacks Investment Research - Mar 04, 2020

It may be time to upgrade your portfolio with the most tenacious blue-chip stocks trading at a discount. Companies with the most durable balance sheets and strongest long-term outlooks that will help...

Moody's (MCO) Is An Incredible Growth Stock: 3 Reasons Why By Zacks Investment Research - Mar 04, 2020

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find...

3 Reasons Why Growth Investors Shouldn't Overlook Century Communities (CCS) By Zacks Investment Research - Mar 04, 2020

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't easy...

Here Is Why Growth Investors Should Buy CACI International (CACI) Now By Zacks Investment Research - Mar 04, 2020

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great...

Here Is Why Growth Investors Should Buy AllianceBernstein (AB) Now By Zacks Investment Research - Mar 04, 2020

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great...

ETFs To Play As Fed Surprises With A Rate Cut By Zacks Investment Research - Mar 04, 2020

Taking investors by a surprise, the U.S. Federal Reserve slashed interest rates on Mar 3 in order to combat the aggravating coronavirus. The rates were cut by a half percentage point to a target range...

Will Second Sight Medical Products (EYES) Report Negative Q4 Earnings? What You Should Know By Zacks Investment Research - Mar 04, 2020

Second Sight Medical Products (EYES) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known...

Clearside Biomedical, Inc. (CLSD) Expected To Beat Earnings Estimates: Can The Stock Move Higher? By Zacks Investment Research - Mar 04, 2020

Wall Street expects a year-over-year increase in earnings on higher revenues when Clearside Biomedical, Inc. (CLSD) reports results for the quarter ended December 2019. While this widely-known...

Analysts Estimate Lexicon Pharmaceuticals (LXRX) To Report A Decline In Earnings: What To Look Out For By Zacks Investment Research - Mar 04, 2020

Lexicon Pharmaceuticals (LXRX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus...

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) To Report A Decline In Earnings: What To Look Out For By Zacks Investment Research - Mar 04, 2020

Crinetics Pharmaceuticals, Inc. (CRNX) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known...

Build-A-Bear (BBW) Earnings Expected To Grow: What To Know Ahead Of Next Week's Release By Zacks Investment Research - Mar 04, 2020

The market expects Build-A-Bear (BBW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus...

Lifetime Brands (LCUT) Reports Next Week: Wall Street Expects Earnings Growth By Zacks Investment Research - Mar 04, 2020

Lifetime Brands (LCUT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook...

Will Correvio Pharma (CORV) Report Negative Q4 Earnings? What You Should Know By Zacks Investment Research - Mar 04, 2020

Wall Street expects a year-over-year increase in earnings on higher revenues when Correvio Pharma (CORV) reports results for the quarter ended December 2019. While this widely-known consensus outlook...